Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis

Author： Konstan Michael W   Accurso Frank J   Nasr Samya Z   Ahrens Richard C   Graff Gavin R  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.8, 2013-08, pp. : 723-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis

By Konstan Michael W   Borowitz Drucy   Mayer-Hamblett Nicole   Milla Carlos   Hendeles Leslie   Murray Susan   Kronmal Richard A   Casey Susan   Rose Lynn M   Morgan Wayne J   Ramsey Bonnie W  

Clinical Investigation, Vol. 3, Iss. 8, 2013-08 ,pp. : 731-741

Future Science

Access to resources Recommend Favorite

CFTR, bicarbonate, and the pathophysiology of cystic fibrosis

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. S40, 2015-10 ,pp. : 2S4-S30

John Wiley & Sons Inc

Access to resources Recommend Favorite

JEJUNAL OBSTRUCTION SECONDARY TO ENTERIC‐COATED POTASSIUM CHLORIDE THERAPY

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 14, Iss. 3, 1966-03 ,pp. : 200-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis

By  

PEDIATRIC PULMONOLOGY, Vol. 43, Iss. 11, 2008-11 ,pp. : 1100-1106

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Pathophysiology of the Pancreatic Defect in Cystic Fibrosis

By  

ACTA PAEDIATRICA, Vol. 78, Iss. S363, 1989-11 ,pp. : 41-44

John Wiley & Sons Inc

Access to resources Recommend Favorite